BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 18507062)

  • 1. Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma.
    Zhao H; Chen Y; Liao YP; Chen HM; Yang QH; Xiao Y; Luo J; Chen ZZ; Yi L; Hu GY
    Clin Exp Med; 2023 Feb; 23(1):55-64. PubMed ID: 35239073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution.
    Kim M; Hwang HS; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
    J Pathol Transl Med; 2021 Sep; 55(5):330-337. PubMed ID: 34465079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL.
    Wang C; Wang Y; Cao J; Sun X; He X; Sun P; Gao T; Huang J; Li Z
    Ann Hematol; 2021 Sep; 100(9):2293-2302. PubMed ID: 33991204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma.
    Yamashita T; Vollbrecht C; Hirsch B; Kleo K; Anagnostopoulos I; Hummel M
    J Clin Exp Hematop; 2020; 60(3):87-96. PubMed ID: 32981916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
    Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
    J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.
    Zeggai S; Harir N; Tou A; Sellam F; Mrabent MN; Salah R
    J Gastrointest Oncol; 2016 Jun; 7(3):462-8. PubMed ID: 27284480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.
    Huang JJ; Xia Y; Wang Y; Liu PP; Bi XW; Sun P; Lin TY; Jiang WQ; Li ZM
    Oncotarget; 2016 Jul; 7(27):41242-41250. PubMed ID: 27183909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
    Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
    Mahjabeen I; Ali K; Zhou X; Kayani MA
    Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis.
    He X; Chen Z; Fu T; Jin X; Yu T; Liang Y; Zhao X; Huang L
    BMC Cancer; 2014 Mar; 14():153. PubMed ID: 24597851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a bioassay to monitor circulating plasma Ki-67.
    Hardiman G
    Leuk Res; 2010 Jul; 34(7):848-9. PubMed ID: 20172610
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
    Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
    Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
    Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
    Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant non-Hodgkin's lymphoma of the joint. Report of two cases, review of the literature and problems of classification].
    Krüger R; Oden J; de Leon F; Dürr W
    Unfallchirurg; 1993 Oct; 96(10):556-62. PubMed ID: 8235678
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.